Skip to main content
. 2014 Jun 6;9:597–611. doi: 10.2147/COPD.S61854

Table 3.

Patient-reported symptoms and rescue-medication use

Total
n=4,343
USA
n=1,001
MEX
n=328
BRA
n=300
FR
n=300
GER
n=300
IT
n=302
SPA
n=303
UK
n=305
NL
n=303
RUS
n=301
JAP
n=300
SK
n=300
Rescue-medication use to relieve daytime symptoms, % using every day or most days 41 55 37 31 36 47 29 56 72 46 21 37 11
Awakenings due to symptoms* at night, % using every night or most nights 41 44 48 49 41 34 46 49 55 34 39 30 23
Nighttime rescue-medication use to relieve symptoms, % using every night or most nights 27 35 35 31 28 23 19 33 60 16 13 16 8
CAT score, mean (SD) mMRC grade 21.5(9.2) 23.3 (8.9) 23.9 (8.3) 24.7 (8.2) 18.3 (9.7) 19.3 (8.2) 19.9(9.7) 18.4(9.2) 24.6 (9.7) 17.2 (8.8) 22.2 (7.4) 16.0(9.2) 24.2 (7.7)
 0–1 53 46 45 41 54 62 46 53 38 68 61 73 52
 ≥2 47 54 55 59 46 38 54 47 62 32 39 27 48

Notes:

During worst month in previous 12 months;

*

coughing, wheezing or shortness of breath. mMRC: modified Medical Research Council dyspnea grade; 0: ‘only breathless with strenuous exercise’; 1: ‘breathless when hurrying on level or up a slight hill’; 2: ‘walk slower than people of same age on the level due to breathlessness or stop for breath when walking on level at own pace’; 3: ‘stop for breath after walking 100 yards or a few minutes on the level’; 4: ‘too breathless to leave house or breathless when dressing’.

Abbreviations: CAT, COPD Assessment Test;24 COPD, chronic obstructive pulmonary disease; SD, standard deviation; mMRC, modified Medical Research Council Scale;25 MEX, Mexico; BRA, Brazil; FR, France; GER, Germany; IT, Italy; SPA, Spain; NL, Netherlands; RUS, Russia; JAP, Japan; SK, South Korea.